SEC Filings for Ayala Pharmaceuticals, Inc.
425 - Prospectuses and communications, business combinations
Form Type: 425
Filing Date: 2021-11-09
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2021-11-09
View Filing
425 - Prospectuses and communications, business combinations
Form Type: 425
Filing Date: 2021-11-08
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2021-11-08
View Filing
DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Form Type: DEFA14A
Filing Date: 2021-11-04
View Filing
DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Form Type: DEFA14A
Filing Date: 2021-11-04
View Filing
DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Form Type: DEFA14A
Filing Date: 2021-11-03
View Filing
DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Form Type: DEFA14A
Filing Date: 2021-10-29
View Filing
DEFM14A - Definitive proxy statement relating to merger or acquisition
Form Type: DEFM14A
Filing Date: 2021-10-21
View Filing
424B3 - Prospectus [Rule 424(b)(3)]
Form Type: 424B3
Filing Date: 2021-10-21
View Filing
